The Hospital of the University of Pennsylvania, one of the largest participants in the 340B drug pricing program, is poised to be granted $86 million by the government as part of a legal settlement, The Philadelphia Inquirer reported Oct. 23.
Read the full post on Becker's Hospital Review - Healthcare News
